Portland biotech firm ImmuCell completes $20 million expansion

November 7, 2017

The new facility, which still needs FDA approval, is designed to produce an antibiotics-free treatment for dairy cows.

(Reprint from Portland Press Herald 11/7/2017) – Biotech firm ImmuCell Corp. of Portland has completed construction on a $20 million, pharmaceutical-grade factory that could help reduce the amount of antibiotics used in the dairy industry. Read more here.